3,14-diazahexacyclo[14.7.1.02,15.04,13.05,10.020,24]tetracosa-1(23),2,4(13),5,7,9,11,14,16,18,20(24),21-dodecaene
-
![3,14-diazahexacyclo[14.7.1.02,15.04,13.05,10.020,24]tetracosa-1(23),2,4(13),5,7,9,11,14,16,18,20(24),21-dodecaene structure](https://file.echemi.com/fileManage/upload/canonicalSmiles/20220812/51a6a7a8af164306b15e04b69ed76bfa.png "3,14-diazahexacyclo[14.7.1.02,15.04,13.05,10.020,24]tetracosa-1(23),2,4(13),5,7,9,11,14,16,18,20(24),21-dodecaene")
3,14-diazahexacyclo[14.7.1.02,15.04,13.05,10.020,24]tetracosa-1(23),2,4(13),5,7,9,11,14,16,18,20(24),21-dodecaene
structure -
-
CAS No:
238-06-2
-
Formula:
C22H12N2
-
Chemical Name:
3,14-diazahexacyclo[14.7.1.02,15.04,13.05,10.020,24]tetracosa-1(23),2,4(13),5,7,9,11,14,16,18,20(24),21-dodecaene
-
Synonyms:
8,9-Benzacenaphtho(1,2-b)quinoxaline;238-06-2;Acenaphtho[1,2-b]benzo[f]quinoxaline;SCHEMBL11796199;DTXSID00178490;NSC80694;ZINC1639582;NSC 80694;NSC-80694;AKOS024332747;MCULE-1616000506
-
CAS No:
3,14-diazahexacyclo[14.7.1.02,15.04,13.05,10.020,24]tetracosa-1(23),2,4(13),5,7,9,11,14,16,18,20(24),21-dodecaene Basic Attributes
304.3 g/mol
304.100048391 g/mol
80694
DTXSID00178490
Safety Information
|Danger|H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]|P261, P264, P270, P271, P273, P280, P301+P310, P302+P352, P304+P340, P305+P351+P338, P310, P312, P321, P330, P332+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Request for Quotation